These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 15477556

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis.
    Sampson JR.
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):592-6. PubMed ID: 12773162
    [Abstract] [Full Text] [Related]

  • 24. Biallelic TSC gene inactivation in tuberous sclerosis complex.
    Crino PB, Aronica E, Baltuch G, Nathanson KL.
    Neurology; 2010 May 25; 74(21):1716-23. PubMed ID: 20498439
    [Abstract] [Full Text] [Related]

  • 25. Multicompartmental distribution of the tuberous sclerosis gene products, hamartin and tuberin.
    Yamamoto Y, Jones KA, Mak BC, Muehlenbachs A, Yeung RS.
    Arch Biochem Biophys; 2002 Aug 15; 404(2):210-7. PubMed ID: 12147258
    [Abstract] [Full Text] [Related]

  • 26. Molecular pathogenesis of tuber formation in tuberous sclerosis complex.
    Crino PB.
    J Child Neurol; 2004 Sep 15; 19(9):716-25. PubMed ID: 15563019
    [Abstract] [Full Text] [Related]

  • 27. Identification and characterization of the interaction between tuberin and 14-3-3zeta.
    Nellist M, Goedbloed MA, de Winter C, Verhaaf B, Jankie A, Reuser AJ, van den Ouweland AM, van der Sluijs P, Halley DJ.
    J Biol Chem; 2002 Oct 18; 277(42):39417-24. PubMed ID: 12176984
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Differential cellular expression of neurotrophins in cortical tubers of the tuberous sclerosis complex.
    Kyin R, Hua Y, Baybis M, Scheithauer B, Kolson D, Uhlmann E, Gutmann D, Crino PB.
    Am J Pathol; 2001 Oct 18; 159(4):1541-54. PubMed ID: 11583980
    [Abstract] [Full Text] [Related]

  • 32. Transgenic expression of dominant negative tuberin through a strong constitutive promoter results in a tissue-specific tuberous sclerosis phenotype in the skin and brain.
    Govindarajan B, Brat DJ, Csete M, Martin WD, Murad E, Litani K, Cohen C, Cerimele F, Nunnelley M, Lefkove B, Yamamoto T, Lee C, Arbiser JL.
    J Biol Chem; 2005 Feb 18; 280(7):5870-4. PubMed ID: 15576369
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. mTOR cascade activation distinguishes tubers from focal cortical dysplasia.
    Baybis M, Yu J, Lee A, Golden JA, Weiner H, McKhann G, Aronica E, Crino PB.
    Ann Neurol; 2004 Oct 18; 56(4):478-87. PubMed ID: 15455405
    [Abstract] [Full Text] [Related]

  • 35. Expression of the tuberous sclerosis complex gene products, hamartin and tuberin, in central nervous system tissues.
    Gutmann DH, Zhang Y, Hasbani MJ, Goldberg MP, Plank TL, Petri Henske E.
    Acta Neuropathol; 2000 Mar 18; 99(3):223-30. PubMed ID: 10663963
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Tumour suppressors hamartin and tuberin: intracellular signalling.
    Krymskaya VP.
    Cell Signal; 2003 Aug 18; 15(8):729-39. PubMed ID: 12781866
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.